FDA approves new use for Edwards' Sapien 3 heart valve
(Reuters) - The U.S. Food and Drug Administration on Monday approved Edwards Lifesciences Corp's Sapien 3 artificial heart valve for high-risk patients whose previously implanted heart valves are failing, a procedure designed to avoid repeat open heart surgery.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cardiology | Food and Drug Administration (FDA) | Health | Heart | Heart Transplant | Heart Valve Disease | Heart Valve Surgery | Heart Valves